Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CHF | -.--% |
|
-.--% | -.--% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Difelikefalin-based Product
100,0
%
| 42 | 100,0 % | 21 | 100,0 % | -49,92% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 42 | 100,0 % | 21 | 100,0 % | -49,92% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 06-08-18 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 12-09-22 |
Scott Terrillion
CMP | Compliance Officer | 61 | 01-11-16 |
Iris Francesconi
IRC | Investor Relations Contact | - | - |
Beth Weinberg
LAW | General Counsel | - | - |
Richard Makara
AUD | Comptroller/Controller/Auditor | 54 | 01-10-14 |
Eric J. Vandal
PRN | Corporate Officer/Principal | - | 02-06-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 01-07-10 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 16-07-14 |
Helen Boudreau
BRD | Director/Board Member | 58 | 02-08-23 |
Chief Executive Officer | 54 | 06-08-18 | |
Susan Shiff
BRD | Director/Board Member | 63 | 26-06-20 |
Lisa von Moltke
BRD | Director/Board Member | 65 | 01-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 675 954 | 46 337 062 ( 84,75 %) | 0 | 84,75 % |
Bedrijfsgegevens
CARA Therapeutics, Inc.
400 Atlantic Street Suite 500
06901, Stamford
+203 406 3700
http://www.caratherapeutics.com![Adres Cara Therapeutics, Inc.(69C)](https://cdn.zonebourse.com/static/address/149356557.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,54% | 94,76 mld. | |
-3,68% | 37,58 mld. | |
-11,61% | 33,3 mld. | |
+74,21% | 27,92 mld. | |
-13,40% | 15,85 mld. | |
-2,29% | 13,79 mld. | |
-12,21% | 11,51 mld. | |
+188,83% | 10,9 mld. | |
-53,94% | 9,27 mld. |
- Beurs
- Aandelen
- Koers CARA
- Koers 69C
- Onderneming Cara Therapeutics, Inc.